For investors seeking momentum, First Trust NASDAQ Pharmaceuticals ETF (FTXH) is probably on the radar. The fund just hit a 52-week high and rose 37.2% from its 52-week low price of $23.29/share.But, are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook to get a better idea of where it might head:FTXH in FocusThe Nasdaq US Smart Pharmaceuticals Index is a modified factor weighted index, designed to provide exposure to US companies within the pharmaceuticals indu ...